BioCorRx BICX
OTC BICX
$0.25 +0.05 (+25.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioCorRx (BICX) Return on Equity [ROE] (2011 - 2025)

Updated

BioCorRx (BICX) reported Return on Equity [ROE] of -365.64% for Q2 2025.

Analysis

BioCorRx (BICX) Return on Equity [ROE] (2011 - 2025) Analysis & Trends

For FY2014, BioCorRx posted Return on Equity [ROE] of -1153.89%, down 990.45 percentage points from FY2013.

  • Return on Equity [ROE] has a three-year change of -1133.17 percentage points (FY2011 to FY2014).
  • By year, Return on Equity [ROE] came in at -163.44% in FY2013 (-143.75 pp), -19.68% in FY2012 (+1.03 pp) and -20.71% in FY2011.
  • The Q2 2025 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 BioCorRx 4.32 Mn 3.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -365.64%
Mar 31, 2015 -1,166.80%
Dec 31, 2014 -735.71%
Mar 31, 2013 -19.11%
Dec 31, 2012 -21.49%
Sep 30, 2012 -25.69%
Jun 30, 2012 -15.64%
Mar 31, 2012 -6.01%
Dec 31, 2011 -9.14%
Sep 30, 2011 -5.08%
API Access

BioCorRx Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BICX&period=max&api_key=YOUR_API_KEY